Serum uric acid and renal prognosis in patients with IgA nephropathy

被引:142
作者
Ohno, I [1 ]
Hosoya, T [1 ]
Gomi, H [1 ]
Ichida, K [1 ]
Okabe, H [1 ]
Hikita, M [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Internal Med 2, Minato Ku, Tokyo 1058461, Japan
关键词
serum uric acid; IgA nephropathy; hyperuricemia; renal prognosis;
D O I
10.1159/000045939
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: This study was designed to elucidate the clinical significance of serum uric acid (SUA) and the relationship between hyperuricemia and renal prognosis in IgA nepropathy. Methods: The correlation between SUA and other clinical parameters were examined in 748 IgA nephropathy patients (432 males and 316 females). Among these patients, 226 (144 males and 82 females) who were followed for more than 5 years were examined for the relationship between hyperuricemia and renal prognosis. Results: In IgA nephropathy, SUA correlated negatively with creatinine clearance (Ccr), and positively with urinary protein and tubulointerstitial damage. SUA was higher in patients with hypertension or diffuse proliferative glomerulonephritis. Hyperuricemia was a risk factor for renal prognosis, both in terms of serum creatinine (p = 0.0025) and Ccr (p = 0.0057). In 56 patients with normal Ccr at renal biopsy, the change of Ccr after more than 8 years was -22.3 +/- 20.8% in 13 patients with hyperuricemia, compared with +2.6 +/- 39.4% in 43 patients without hyperuricemia (p = 0.0238), Hyperuricemia was related independently to deterioration of Ccr (p = 0.0461), Conclusion: Hyperuricemia in IgA nephropathy is derived from both glomerular and tubulointerstitial damage, and correlated with hypertension. Hyperuricemia is a risk factor for renal prognosis in IgA nephropathy. Copyright (C) 2001 S. Karger AG. Basel.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 22 条
[1]   Serum uric acid and cardiovascular events in successfully treated hypertensive patients [J].
Alderman, MH ;
Cohen, H ;
Madhavan, S ;
Kivlighn, S .
HYPERTENSION, 1999, 34 (01) :144-150
[2]   LONG-TERM BENEFITS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY IN PATIENTS WITH SEVERE IMMUNOGLOBULIN A NEPHROPATHY - A COMPARISON TO PATIENTS RECEIVING TREATMENT WITH OTHER ANTIHYPERTENSIVE AGENTS AND TO PATIENTS RECEIVING NO THERAPY [J].
CATTRAN, DC ;
GREENWOOD, C ;
RITCHIE, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :247-254
[3]   Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[4]   URIC-ACID IN ADVANCED RENAL-FAILURE [J].
DANOVITCH, GM ;
BERLYNE, GM ;
WEINBERGER, J .
CLINICAL SCIENCE, 1972, 43 (03) :331-+
[5]  
DEZEEUW D, 1995, CAN J CARDIOL, V11, pF41
[6]   ENHANCED ENTERIC EXCRETION OF URATE IN RATS WITH CHRONIC-RENAL-FAILURE [J].
HATCH, M ;
VAZIRI, ND .
CLINICAL SCIENCE, 1994, 86 (05) :511-516
[7]   Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis [J].
Hooper, DC ;
Spitsin, S ;
Kean, RB ;
Champion, JM ;
Dickson, GM ;
Chaudhry, I ;
Koprowski, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :675-680
[8]   Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension [J].
Johnson, RJ ;
Schreiner, GF .
KIDNEY INTERNATIONAL, 1997, 52 (05) :1169-1179
[9]   Natural history and risk factors for immunoglobulin A nephropathy in Japan [J].
Koyama, A ;
Igarashi, M ;
Kobayashi, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (04) :526-532
[10]   WORLDWIDE PERSPECTIVE OF IGA NEPHROPATHY [J].
LEVY, M ;
BERGER, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (05) :340-347